These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

157 related articles for article (PubMed ID: 3545950)

  • 1. Time course of islet cell antibodies and beta-cell function in non-insulin-dependent stage of type I diabetes.
    Kobayashi T; Itoh T; Kosaka K; Sato K; Tsuji K
    Diabetes; 1987 Apr; 36(4):510-7. PubMed ID: 3545950
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Relationship between insulin-dependent diabetes mellitus (IDDM) and non-insulin-dependent diabetes mellitus: beta-cell function, islet cell antibody, and haptoglobin in parents of IDDM patients.
    Kajio H; Kobayashi T; Nakanishi K; Okubo M; Tsukada T; Nakayama T; Yamada N; Murase T; Yazaki Y; Kosaka K
    Metabolism; 1995 Jul; 44(7):869-75. PubMed ID: 7616845
    [TBL] [Abstract][Full Text] [Related]  

  • 3. The prevalence of islet cell antibodies in Japanese insulin-dependent and non-insulin-dependent diabetic patients studied by indirect immunofluorescence and by a new method.
    Kobayashi T; Sugimoto T; Itoh T; Kosaka K; Tanaka T; Suwa S; Sato K; Tsuji K
    Diabetes; 1986 Mar; 35(3):335-40. PubMed ID: 3512344
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Relationships among islet cell antibodies, residual beta-cell function, and metabolic control in patients with insulin-dependent diabetes mellitus of long duration: use of a sensitive C-peptide radioimmunoassay.
    Nakanishi K; Kobayashi T; Miyashita H; Ohkubo M; Sugimoto T; Murase T; Kosaka K; Inouye K; Kono M
    Metabolism; 1990 Sep; 39(9):925-30. PubMed ID: 2202883
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Small doses of subcutaneous insulin as a strategy for preventing slowly progressive beta-cell failure in islet cell antibody-positive patients with clinical features of NIDDM.
    Kobayashi T; Nakanishi K; Murase T; Kosaka K
    Diabetes; 1996 May; 45(5):622-6. PubMed ID: 8621013
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Maleness as risk factor for slowly progressive IDDM.
    Kobayashi T; Nakanishi K; Sugimoto T; Itoh T; Murase T; Kosaka K; Tsuji K
    Diabetes Care; 1989 Jan; 12(1):7-11. PubMed ID: 2653752
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Relationship between first-phase insulin secretion and age, HLA, islet cell antibody status, and development of type I diabetes in 220 juvenile first-degree relatives of diabetic patients.
    Robert JJ; Deschamps I; Chevenne D; Roger M; Mogenet A; Boitard C
    Diabetes Care; 1991 Aug; 14(8):718-23. PubMed ID: 1954807
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Predictive value of insulin autoantibodies for further progression of beta cell dysfunction in non-insulin-dependent diabetics.
    Nakanishi K; Kobayashi T; Sugimoto T; Murase T; Itoh T; Kosaka K
    Diabetes Res; 1988 Nov; 9(3):105-9. PubMed ID: 3072143
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Immunogenetic and clinical characterization of slowly progressive IDDM.
    Kobayashi T; Tamemoto K; Nakanishi K; Kato N; Okubo M; Kajio H; Sugimoto T; Murase T; Kosaka K
    Diabetes Care; 1993 May; 16(5):780-8. PubMed ID: 8098691
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Glucose tolerance and insulin response in parents of patients with insulin-dependent and juvenile-onset non-insulin-dependent diabetes mellitus.
    Matsuda A; Kuzuya T
    Diabetes Res Clin Pract; 1992 Apr; 16(1):37-46. PubMed ID: 1576930
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Nonprogression of subclinical beta-cell dysfunction among first-degree relatives of IDDM patients. 5-yr follow-up of the Seattle Family Study.
    McCulloch DK; Klaff LJ; Kahn SE; Schoenfeld SL; Greenbaum CJ; Mauseth RS; Benson EA; Nepom GT; Shewey L; Palmer JP
    Diabetes; 1990 May; 39(5):549-56. PubMed ID: 2185106
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Beta-cell function in relation to islet cell antibodies during the first 3 yr after clinical diagnosis of diabetes in type II diabetic patients.
    Gottsäter A; Landin-Olsson M; Fernlund P; Lernmark A; Sundkvist G
    Diabetes Care; 1993 Jun; 16(6):902-10. PubMed ID: 8325204
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Elevated proinsulin levels related to islet cell antibodies in first-degree relatives of IDDM patients.
    Spinas GA; Snorgaard O; Hartling SG; Oberholzer M; Berger W
    Diabetes Care; 1992 May; 15(5):632-7. PubMed ID: 1516482
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Analysis of families at risk for insulin-dependent diabetes mellitus reveals that HLA antigens influence progression to clinical disease.
    Honeyman MC; Harrison LC; Drummond B; Colman PG; Tait BD
    Mol Med; 1995 Jul; 1(5):576-82. PubMed ID: 8529124
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Immunogenetic and nutritional profile in insulin-using youth-onset diabetics in Korea.
    Huh KB; Lee HC; Kim HM; Cho YW; Kim YL; Lee KW; Lee EJ; Lim SK; Kim DH; Yoon JW
    Diabetes Res Clin Pract; 1992 Apr; 16(1):63-70. PubMed ID: 1576933
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Metabolic, hormonal, and immunological alterations in subjects with antecedent mumps infection.
    Ratzmann KP; Strese J; Rjasanowski I; Witt S; Kohnert KD; Keilacker H; Richter KV; Giebelmann R; Schulz B
    Exp Clin Endocrinol; 1985 Dec; 86(3):323-34. PubMed ID: 3912201
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Correlation between islet cell antibodies and anti-cytomegalovirus IgM and IgG antibodies in healthy first-degree relatives of type 1 (insulin-dependent) diabetic patients.
    Nicoletti F; Scalia G; Lunetta M; Condorelli F; Di Mauro M; Barcellini W; Stracuzzi S; Pagano M; Meroni PL
    Clin Immunol Immunopathol; 1990 Apr; 55(1):139-47. PubMed ID: 2155076
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Islet-cell cytoplasmic antibodies in Japanese diabetics.
    Shinjyo T; Hirata Y; Maruyama H; Ishiba S; Matuura N; Fukushima N; Wakisaka A
    Tohoku J Exp Med; 1983 Dec; 141 Suppl():265-9. PubMed ID: 6393434
    [TBL] [Abstract][Full Text] [Related]  

  • 19. HLA antigens, cytoplasmic islet cell antibodies, and carbohydrate tolerance in families of children with insulin-dependent diabetes mellitus.
    Ginsberg-Fellner F; Dobersen MJ; Witt ME; Rayfield EJ; Rubinstein P; Notkins AL
    Diabetes; 1982 Apr; 31(4 Pt 1):292-8. PubMed ID: 6759245
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Residual beta-cell function and HLA-A24 in IDDM. Markers of glycemic control and subsequent development of diabetic retinopathy.
    Nakanishi K; Kobayashi T; Inoko H; Tsuji K; Murase T; Kosaka K
    Diabetes; 1995 Nov; 44(11):1334-9. PubMed ID: 7589833
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.